The global organ preservation market is projected to reach USD 455 million by 2032, expanding at a compound annual growth rate (CAGR) of 6.4%. This growth is driven by the increasing demand for organ transplants, rising rates of organ failure, and the growing prevalence of chronic diseases that lead to organ damage.
The rising incidence of conditions such as chronic kidney disease, liver cirrhosis, and heart failure is fueling the need for effective organ preservation solutions. As the global population ages and the prevalence of lifestyle-related diseases increases, the demand for organ transplants is expected to rise. In particular, kidney transplant rates are anticipated to grow due to the rising cases of kidney failure and chronic kidney disease, further driving the need for improved organ preservation methods.
Moreover, increased investments in healthcare infrastructure and technology, along with the growing focus on organ transplant programs, are expected to contribute to the market’s expansion. Advancements in preservation techniques and the development of more efficient and reliable preservation solutions are enhancing the success rates of organ transplants, ensuring better outcomes for recipients.
Request a Sample Report Now to get Premium Insights: https://www.fmisamplereport.com/sample/rep-gb-14363
Key Takeaways:
- The global organ preservation market is expected to reach USD 455 million by 2032, with a CAGR of 6.4%.
- Rising organ failure rates and the growing need for transplants, especially in kidney patients, are key drivers of market growth.
- Investments in healthcare and advancements in organ preservation technologies are further supporting market expansion.
- The increasing prevalence of chronic diseases is expected to accelerate the demand for organ preservation solutions.
Global organ preservation market value is estimated to reach USD 455 Million by 2032, with a compound annual growth rate of 6.4%.
- Growing demand for organ transplants and organ failures is expected to drive the market
- A growing number of diseases is expected to propel market growth for the organ preservation market
- Investments in healthcare will promote organ preservation growth.
- Kidney transplant rates will rise due to increased cases of kidney failure and chronic kidney disease.
The process of preserving healthy organs from a donor so that they can be transplanted into the body of a recipient is called organ preservation. Static cold storage (SCS) aids in maintaining normal organ function after transplantation by preventing harmful metabolites from degrading healthy tissue.
How is the Competitive Landscape for different Key Players of the Global Organ Preservation Market?
The key players in the organ preservation driving the global market are XVIVO Perfusion AB, Dr. Franz Kohler Chemie GmbH, Essential Pharmaceuticals LLC, Trans Medics, Organ Ox Limited, Shanghai Genext Medical Technology, Bridge to Life Limited, Waters Medical Systems, Preservation Solutions, Carnamedica, and Transplant Biomedicals.
All the prominent players dealing in organ preservation have continually adopted the advancing technologies and have changed the course of organ preservation from the past to the future to provide the best service for patients in need.
In recent years they have been focusing on mergers and collaboration to expand the customer base in traditionally less popular regions.
Some of the Recent Developments in the Organ Preservation Market:
- Paragonix Technologies of the USA expanded its product offerings in the USA and Europe to strengthen its geographic presence by launching a LIVERgaurd Donor Liver Preservation System in 2021.
- To gain access to transplantation networks in Latin America in 2021, XVIVO Perfusion of Sweden partnered with Contatti Medical of Brazil.
- Institute Georges Lopez (IgI) of France set up a manufacturing facility in Tamil Nadu, India, in 2021 for expanding its business in medical devices and organ preservation solutions required for the flushing and preservation of organs.
- OCS Heart System prepared by Transmedics company of USA received premedical approval from Food and Drug Administration (FDA) in 2021 for use with organs obtained from donors after brain death (DBD).
- For the distribution and marketing of custodial HTK solutions in the Chinese and Asia Pacific markets Dr. Franz Köhler Chemie GmbH, Melchers Group, and CICEL of Germany started a joint venture in 2020 by the name of Köhler Pharmaceuticals in Beijing.
Key Segments
By Solution:
- The University of Wisconsin Solution (UW Solution)
- Custodial HTK
- Perfadex
- Other Solutions
By Technique:
- Static Cold Storage
- Hypothermia Machine Perfusion
- Normothermic Machine Perfusion
By Organ Type:
- Kidney
- Liver
- Long
- Heart
- Pancreas
By End User:
- Organ Transplant Centres
- Hospitals
- Specialty Clinics
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
